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Purpose: To investigate the impact of cataract surgery and blood pressure changes induced 
by one week of sodium restriction on retinal vascular diameter.
Methods: Fundus photographs of 200 patients were obtained before and one week after cataract 
surgery. For one week after admission, 100 patients received sodium restriction and 100 patients 
(ie, the control group) did not receive sodium restriction. The diameter of the retinal vessels 
and blood pressure were compared between the sodium restriction group and the control group. 
The vascular diameter was measured using an objective computer-based method.
Results: Neither group had a significant change in the diameter of the retinal vessels after 
cataract surgery. Although there was no significant change in retinal arterial and venular 
diameter in the sodium restriction group, one-week sodium restriction significantly reduced 
mean blood   pressure. However, multiple linear regression analyses indicated that an increase 
in retinal arteriolar diameter was significantly associated with diabetes, hyperlipidemia, and 
alcohol intake.
Conclusion: Cataract surgery and blood pressure reduction induced by one week of sodium 
restriction resulted in no significant change in retinal arteriolar diameter.
Keywords: cataract surgery, hypertension, retinal blood vessel diameter, retinal fundus camera, 
sodium restriction.
Introduction
An excessive sodium intake raises blood pressure by changing arterial function and 
structure and by expanding intravascular volume and increasing vascular resistance.1–3 
In Japan, the guidelines for hypertension treatment recommend restricting sodium 
intake to 6 g or less per day. However, the mean daily sodium intake of Japanese 
people is as high as 11 g, which makes sodium restriction for patients with hyperten-
sion an important task.4 Because hypertension is a major risk factor for cerebrovascular 
  disorders, sodium restriction is clearly important.5
The fundus vessels are the only vessels in the human body that can be directly 
observed noninvasively. This permits evaluation of the retinal vessels. A retinal vascular 
abnormality is the most important factor in the early detection of hypertension and 
cerebrovascular disorders, and retinal vascular narrowing is the first fundus change 
caused by hypertension.6 This has been used to determine the severity of arterioscle-
rosis and hypertension. However, the evaluation is subjective, and methods for more 
objective measurements are unavailable. Conventional methods using visual inspection 
to measure the diameter of retinal vessels also tend to overlook early-stage changes. 
This prevents the identification of cerebrovascular disorders at an early stage.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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To address this problem, a method has been developed 
that uses computer software and digital processing to quan-
tify retinal arteriolar narrowing.7–9 In this method, a high-
resolution scanner takes digitized fundus photographs, and a 
software program measures the diameter of retinal arterioles 
and venules. The software program measures with a greater 
accuracy and objectivity than is possible with conventional 
methods.
The cross-sectional Beaver Dam Eye Study used this 
method and demonstrated that retinal arteriolar diameter 
decreased by 4.0 µm with each 10 mmHg increase in mean 
arterial blood pressure. This indicates the potential of this 
method for evaluating small changes in the diameter of reti-
nal vessels that are associated with blood pressure   changes.7 
Using the same method, the Japanese epidemiologic   Funagata 
study showed a relationship between increases in mean blood 
pressure and narrowing of retinal arteriolar   diameter.10 
  Previous epidemiologic studies have reported that age, 
gender, hypertension, systolic and diastolic blood pressures, 
diabetes mellitus, a history of smoking, total cholesterol 
level, body mass index (BMI), and a history of alcohol intake 
impact retinal vessel diameter.11,12 Some research suggests 
that retinal arteriolar caliber may be narrower in people with 
hypertension and hyperlipidemia.11 A large retinal venular 
caliber reportedly predicts the progression of retinopathy in 
people with diabetes. There is evidence that retinal venular 
caliber may be influenced by systemic inflammation.12
Many studies have shown a relationship between increased 
blood pressure and narrowing of retinal vascular diameter. 
However, only a few studies have examined the relationship 
between a decrease in blood pressure and a change in vascular 
diameter, including retinal vascular diameter.13,14
Unlike sclerotic changes, which are irreversible, the 
narrowing of retinal blood vessels appears to be reversible.6 
At a clinical site, it is essential to know the minimum dos-
ing period for antihypertensive treatment that is needed to 
improve narrowing of retinal vascular diameter.   Predicting 
this dose accurately will similarly ease the burden on 
  arterioles in the brain and kidney, and therefore may be 
therapeutically important.
Cataract is the leading cause of blindness worldwide, and 
cataract surgery is the most frequent surgical procedure in 
people aged 65 years or older in the Western world, including 
Japan.15–17 As the Japanese population ages, the prevalence 
of visual impairment is projected to increase from 1.35% 
in 2007 to 2.0% by 2050; hence, visual impairment due to 
cataract is on the increase.18 Therefore, an important chal-
lenge is assessing the effect of cataract surgery on vascular 
changes because the increasing elderly population is directly 
linked with the rise in the number of cataract patients having 
systemic chronic diseases, including heart disease, stroke, 
and diabetes. The invasiveness of cataract surgery induces 
the production of prostaglandins and other inflammatory 
cytokines. However, the relationship between these proin-
flammatory markers and changes in retinal vascular diameter 
has not been examined.19
In the current study, patients were treated with sodium 
restriction for one week after admission. The impact of 
blood pressure changes induced by sodium restriction on 
retinal vascular diameter was assessed. Changes in diameter 
of the retinal vessels before and after cataract surgery were 
also examined. To our knowledge, this is the first clinical 
study in Japan to use computerized measurements of retinal 
vascular diameter.
Patients and methods
retinal assessment
The subjects were 200 patients (92 males, 108 females, mean 
age ± standard deviation [SD] 76.4 ± 8.0 years)   admitted 
between January 2009 and July 2009 to the Juntendo Tokyo 
Koto Geriatric Medical Center for cataract surgery. None had 
a history of renal dysfunction or abnormal blood   biochemistry. 
Patients with renal dysfunction, including renal failure, were 
excluded because they are often undergoing dialysis, strict 
fluid restriction, and diet therapy, ie, factors that make them 
unsuitable for evaluation of the effect of sodium restriction. 
Patients who had retinal disease, including severe diabetic 
retinopathy, were considered unsuitable for evaluation of 
retinal vessel diameter and were therefore excluded.
The control group consisted of 100 patients who all gave 
informed consent. Before surgery and one week after surgery, 
the blood pressure of each patient was measured and poste-
rior pole retina-centered fundus photographs were obtained. 
Diameter of the retinal vessels was measured quantitatively, 
and changes in mean blood pressure and in diameter of the 
retinal vessels were evaluated. During the week of the study, 
the control patients received a regular diet with no sodium 
restriction (ie, 10 g sodium per day).
For one week after admission, the remaining 100 patients 
received a sodium-restricted diet of 5 g sodium per day 
(ie, the sodium restriction group). At admission and one week 
after surgery, each patient’s blood pressure was measured 
and posterior pole retina-centered fundus photographs were 
obtained. The diameter of the retinal vessels was measured 
quantitatively, and the extent of diffuse narrowing of the 
retinal vascular diameter was evaluated.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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All patients underwent cataract surgery of both eyes. The 
procedure utilized phacoemulsification and intraocular lens 
implantation.
A nonstereoscopic 45° nonmydriatic fundus camera 
(Nonmyd7, Kowa Inc, Nagoya, Japan) obtained retinal 
photographs of both eyes for each patient. One field was 
centered between the macula and optic disc. A retinal pho-
tograph was ungradable if more than one arteriole or venule 
with a diameter greater than 40 µm could not be measured 
after three attempts. All retinal vessel measurements were 
obtained from the right eye. A trained grader graded the 
arteriolar and venular diameters. The grader used a standard-
ized protocol with a computer-assisted method having high 
  reproducibility.8 In these analyses, the fundus image covered 
a sufficient area in a zone lying 0.5 to 1 disc diameter away 
from the disc margin (referred to as zone B).
Details of image preparation and grading protocols 
have been described previously.8,9 A digitized grid was 
placed over the image and centered on the optic disc. All 
vessels passing completely through zone B were measured 
using image analysis software (Retinal Analysis, Depart-
ment of Ophthalmology and Visual Sciences, University of 
  Wisconsin, Madison, WI). The grader identified each vessel 
as either an arteriole or venule. The software calculated the 
average width from five equidistant measurements of each 
vessel. The average retinal arteriolar or venular diameter for 
each eye was calculated using the Parr–Hubbard formula. 
They were then summarized as the central retinal arteriolar 
equivalent (CRAE) or the central retinal venular equivalent 
(CRVE).20,21
Each subject gave informed consent at the beginning of 
the examination. This study was conducted in accordance 
with the recommendations of the Declaration of Helsinki. The 
Institutional Review Board at Juntendo Tokyo Koto Geriatric 
Medical Center (Tokyo, Japan) approved the study.
systemic assessment
Using a single mercury sphygmomanometer, the brachial 
systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) were measured once at each examination with the 
patient in a sitting position after a five-minute rest period. 
Mean arterial blood pressure was calculated as (0.33 × SBP) + 
(0.67 × DBP).7 The 2003 World Health Organization (WHO) 
guidelines were used to classify blood pressure as “normal” 
for an SBP of 120 mmHg or less and a DBP of 80 mmHg or 
less; as “high normal” for an SBP of 121 to 139 mmHg or 
a DBP of 81 to 89 mmHg; as “hypertension Stage I” for an 
SBP of 140 to 159 mmHg or a DBP of 90 to 99 mmHg; and 
as “hypertension Stage II” or above for an SBP of 160 mmHg 
or greater and a DBP of 100 mmHg or greater.22   Hypertension 
was classified in patients who were at Stage I or II or in 
patients who had received treatment for hypertension.
Diabetes was defined according to WHO guidelines, ie, a 
fasting glucose level of 126 mg/dL (7.0 mmol/L) or greater, 
a nonfasting glucose level of 200 mg/dL (11.1 mmol/L) or 
greater, or a history of or current treatment for diabetes.23
A diagnosis of hyperlipidemia was based on the diag-
nostic criteria of the Japan Atherosclerosis Society and was 
defined as either a total cholesterol level of 220 mg/dL or 
greater, a low-density lipoprotein cholesterol (LDL-C) level 
of 140 mg/dL or greater in fasting blood samples; or a history 
of or current treatment for hyperlipidemia.24 In the US, the 
National Cholesterol Education Program (NCEP) has defined 
hyperlipidemia as a total cholesterol level of 240 mg/dL or 
more and an LDL-C level of 160 mg/dL or more, based on 
the relationship between total cholesterol levels and rates 
of coronary death in the Multiple Risk Factor Intervention 
Trial.25,26 In Japan, the criteria for hyperlipidemia, ie, a total 
cholesterol level of 220 mg/dL or greater and an LDL-C level 
of 140 mg/dL or greater, are based on an epidemiologic study 
(NIPPON DATA80).27
The Brinkman Index (ie, daily consumption of 
  cigarettes × years of smoking) was used in the analysis of a 
patient’s smoking status.28 Based on an interview, a patient’s 
alcohol intake (including consumption within the past year) 
was classified into one of two categories, ie, noncurrent or 
current intake.
A patient’s BMI was calculated as weight in kilograms 
divided by the square of height in meters.
statistical analysis
The extent of change in CRAE, CRVE, mean arterial blood 
pressure, SBP, and DBP in patients in the sodium restriction 
group and in patients in the control group was compared 
using paired t-tests. Within the sodium restriction group 
and the control group, the differences in the CRAE, CRVE, 
mean arterial blood pressure, SBP, and DBP after surgery 
were tested by unpaired t-tests. Simple regression analyses 
and multiple regression analyses were used to examine the 
association of the differences in CRAE and CRVE between 
the two groups and background factors (ie, age, gender, mean 
arterial blood pressure, diabetes mellitus, hyperlipidemia, 
Brinkman Index, alcohol intake, and BMI).
Three models were used in the multiregression analysis. 
In model 1, factors with significant differences in single 
regression analysis were added and analyzed. In model 2, Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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the factors used in model 1 and the Brinkman Index (a factor 
showing no significant difference for retinal venular caliber 
in single regression analysis but with 0.05 , P , 0.10) were 
added and analyzed. The Brinkman Index was added to the 
factors used in model 1 to make the analysis for model 2 
because a relationship between smoking and retinal blood 
vessel diameter has been reported in an earlier epidemiologic 
study and because a causal relationship between smoking and 
arterial sclerosis is already proven. In model 3, an analysis 
was performed for all factors. Each model included age and 
gender as factors. The significance level was set at P , 0.05. 
Because patients with hypertension were on treatment and 
some had normal blood pressure, the mean arterial blood 
pressure, rather than hypertension itself, was used in the 
analysis.
All data were stored at Juntendo University and analyzed 
using SPSS16.0 J for Windows (SPSS Inc, Chicago, IL).
Results
None of the patients had complications after cataract surgery. 
Table 1 shows the age, gender, BMI, hypertension, mean 
arterial blood pressure, diabetes mellitus, hyperlipidemia, 
Brinkman Index, and alcohol intake for patients in the sodium 
restriction group and in the control group (n = 100 in each 
group). The association between age, BMI, mean arterial 
blood pressure, and Brinkman Index was analyzed by an 
unpaired t-test; all other characteristics were analyzed by 
the χ2 test. Most background factors were similar in the 
two groups, but the age of the sodium restriction group 
(78.0 ± 4.9 years) was higher than that of the control group 
(74.9 ± 10 years). The rate of hypertension was also higher 
in the sodium restriction group. The rates of hyperlipidemia 
and Brinkman Index were higher in the control group.
In the sodium restriction group, CRAE values before and 
after surgery were 140.2 ± 13.1 µm and 140.5 ± 14.0 µm, 
respectively; and in the control group, 143.4 ± 17.5 µm and 
144.2 ± 16.2 µm, respectively. The increase in CRAE after 
surgery was not significant in the sodium restriction and 
control groups (0.3 ± 9.3 µm and 0.8 ± 7.8 µm, respectively, 
Table 2).
CRVE values before and after surgery were 211.3 ± 27.6 µm 
and 214.1 ± 28.7 µm, respectively, in the sodium restriction 
group, and were 217.4 ± 23.4 µm and 218.4 ± 24.0 µm, 
respectively, in the control group. The 2.8 ± 12.9 µm increase 
in CRVE after surgery in the sodium restriction group was 
significant. The 0.9 ± 11.9 µm increase in CRVE after surgery 
in the control group was not significant.
Mean arterial blood pressure before and after surgery 
was 87.6 ± 6.9 and 83.1 ± 6.5 mmHg, respectively, in the 
sodium restriction group; the −4.4 ± 6.9 mmHg decrease 
after surgery was significant. In the control group, the mean 
arterial blood pressure values before and after surgery were 
Table 1 Characteristics of the sodium restriction group and the control group
Sodium restriction
group (n = 100)
Control group
(n = 100)
P value
Age (years) 78.0 ± 4.9 74.9 ± 10 0.006**
gender
  Male
  Female
48 (48%)
52 (52%)
44 (44%)
56 (56%)
ns
BMi 24.0 ± 4.5 24.0 ± 4.1 ns
hypertension
 +
 −
86 (86%)
14 (14%)
60 (60%)
40 (40%)
,0.001**
%
MABP (before surgery) 87.6 ± 6.9 87.1 ± 9.5 0.674
Diabetes
  +
  −
35 (35%)
65 (65%)
36 (36%)
64 (64%)
ns
hyperlipidemia
 +
 −
46 (46%)
54 (54%)
64 (64%)
36 (36%)
0.016*
%
Current alcohol intake
 +
 −
26 (26%)
74 (74%)
28 (28%)
72 (72%)
ns
%
Brinkman index
median (25th–75th)
65.8 ± 206.9
0 (0–0)
139 ± 289.1
0 (0–200)
0.041*
,0.001**
Notes: Data are shown as n (%) or as the mean ± standard deviation; *P based on the unpaired t-test (for age [Welch’s t-test], BMI, MABP, and Brinkman Index), the 
Wilcoxon signed rank test (for the median Brinkman Index), and the χ2 test (for all characteristics, except for age, BMI, MABP, and Brinkman Index. *P , 0.05; **P , 0.01).
Abbreviations: BMI, body mass index; MABP, mean arterial blood pressure; ns, not significant.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Table 2 Change in blood pressure and retinal vessel caliber before and after cataract surgery in the sodium restriction group and in 
the control group
Before surgery After surgery Change Percentage change P value
retinal arteriolar 
caliber (µm)
sodium restriction group 
(n = 100)
Control group (n = 100)
140.2 ± 13.1
 
143.4 ± 17.5
140.5 ± 14.0
 
144.2 ± 16.2
0.3 ± 9.3
 
0.8 ± 7.8
0.2%
 
0.6%
0.732
 
0.296
Change (sodium restriction group vs control group) ns
retinal venular
caliber (µm)
sodium restriction group 
(n = 100)
Control group (n = 100)
211.3 ± 27.6
 
217.4 ± 23.4
214.1 ± 28.7
 
218.4 ± 24.0
2.8 ± 12.9
 
0.9 ± 11.9
1.3%
 
0.4%
0.031*
 
0.435
Change (sodium restriction group vs control group) ns
MABP (mmhg) sodium restriction group 
(n = 100)
Control group (n = 100)
87.6 ± 6.9
 
87.1 ± 9.5
83.1 ± 6.5
 
86.5 ± 8.7
−4.4 ± 6.9
 
−0.6 ± 6.5
−5.0%
 
−0.6%
,0.001**
 
0.397
Change (sodium restriction group vs control group) ,0.001**
sBP (mmhg) sodium restriction group 
(n = 100)
Control group (n = 100)
133.5 ± 12.7
 
121.5 ± 14.9
123.3 ± 11.1
 
124.4 ± 12.7
−10.2 ± 16.4
 
2.9 ± 16.4
−7.6%
 
2.4%
,0.001**
 
,0.001**
Change (sodium restriction group vs control group) ,0.001**
DBP (mmhg) sodium restriction group 
(n = 100)
Control group (n = 100)
70.7 ± 8.8
 
67.0 ± 6.6
65.9 ± 6.8
 
67.0 ± 6.7
−4.8 ± 10.9
 
−0.1 ± 8.8
−6.8%
 
−0.1%
0.081
 
0.946
Change (sodium restriction group vs control group) 0.001**
Notes: *P , 0.05; **P , 0.01. The before vs after cataract surgery association was analyzed by paired t-test. The sodium restriction group vs the control group association 
was analyzed by unpaired t-test; the amount of change was determined by the formula: change = after surgery − before surgery; percentage of change was determined by the 
formula: percentage change = (after surgery − before surgery) ÷ before surgery.
Abbreviations: DBP, diastolic blood pressure; MABP, mean arterial blood pressure; SBP, systolic blood pressure; ns, not significant.
87.1 ± 9.5 mmHg and 86.5 ± 8.7 mmHg, respectively; 
the −0.6 ± 6.5 mmHg decrease was not significant.
In the sodium restriction group, SBP before and after 
surgery was 133.5 ± 12.7 mmHg and 123.3 ± 11.1 mmHg, 
respectively; the −10.2 ± 16.4 mmHg decrease after surgery 
was significant. In the control group, the SBP before and after 
surgery was 121.5 ± 14.9 mmHg and 124.4 ± 12.7 mmHg, 
respectively; the 2.9 ± 16.4 mmHg increase after surgery 
was significant.
Both groups had no significant change in DBP before 
and after surgery. In the sodium restriction group, DBP 
decreased by −4.8 ± 10.9 mmHg after surgery, having been 
70.7 ± 8.8 mmHg before surgery and 65.9 ± 6.8 mmHg after 
surgery. In the control group, the DBP decreased after surgery 
by 0.1 ± 8.8 mmHg, having been 67.0 ± 6.6 mmHg before 
surgery and 67.0 ± 6.7 mmHg after surgery. The changes in 
mean arterial blood pressure, SBP, and DBP in the sodium 
restriction group differed significantly from their respective 
changes in the control group.
Simple regression analyses were used to examine the 
association of differences in CRAE and in CRVE before 
and after cataract surgery (with a one-week hospitalization) 
in relation to age, gender, mean arterial blood pressure, 
diabetes mellitus, hyperlipidemia, Brinkman Index, alcohol 
intake, and BMI. The analyses demonstrated that an increase 
in CRAE was significantly associated with gender, diabetes 
mellitus, hyperlipidemia, alcohol intake, and BMI (Table 3), 
that an increase in CRVE was significantly associated with 
age, and that a decrease in CRVE was significantly associated 
with hyperlipidemia (Table 4).
Multiple regression analyses were used to examine the 
association of differences in CRAE and CRVE before and 
after cataract surgery and a one-week hospitalization with 
the factors listed earlier. The analyses revealed that an 
increase in CRAE was significantly associated with diabe-
tes mellitus, hyperlipidemia, and alcohol intake (Table 3), 
that an increase in CRVE was significantly associated with 
age and Brinkman Index, and that a decrease in CRVE was 
significantly associated with hyperlipidemia (Table 4). 
In multiregression analysis, the analysis results in models 1 
and 2 were the same as those in model 3 (a saturated model 
with all factors included). Furthermore, hyperlipidemia in 
this study was analyzed based on the Japanese diagnostic 
criteria. However, performing an analysis based on the 
criteria of the NCEP produced the same results (results 
not shown).
Discussion
Epidemiologic surveys and interventional trials have shown 
that an excessive intake of sodium causes hypertension and Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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that high blood pressure is a risk factor for ischemic heart 
  disease and cerebrovascular disorders.5,29–31 The   INTERSALT 
study has demonstrated that the sodium intake of   Japanese 
people was about 12 g/day (based on 24-hour urine 
  collection) and that subjects consuming 3 g or less per day of 
salt equivalent (based on sodium excretion) had lower blood 
pressure.32 An increase in sodium intake of 100 mmol/day 
(equivalent to about 6 g/day) has been shown to raise SBP by 
6 mmHg (by about 3 mmHg adjusted by weight). This reveals 
a correlation between sodium intake and blood pressure.32 
The DASH-Sodium Trial also indicates that sodium intake 
influences blood pressure, and that a lower sodium intake is 
associated with a lower blood pressure.33
A hypertensive fundus change (ie, narrowing of the 
retinal vessels occurring at an early stage) is an important 
risk factor for the onset of cerebrovascular disorders.6 The 
relationship between antihypertensive drugs and changes in 
the retinal vessels has been evaluated, but the relationship 
between sodium restriction and retinal vascular diameter 
has not been examined.13 Therefore, in this study we evalu-
ated changes in the diameter of retinal vessels and changes 
in mean blood pressure due to sodium restriction for one 
week. This short period of sodium restriction significantly 
reduced mean arterial blood pressure in our study, and this 
finding has previously been demonstrated.33 The change in 
mean arterial blood pressure before and after cataract surgery 
also differed significantly between the sodium restriction and 
control groups. Sodium restriction also significantly reduced 
SBP. DBP was not reduced significantly, but the change after 
surgery differed significantly between the two groups.
It is generally understood that an excessive intake of 
sodium increases the volume of circulating blood, raises 
blood pressure, and changes arterial parameters such as 
vascular resistance without affecting blood pressure.1–3 The 
decrease in blood pressure in our study probably occurred 
through reduction of the circulating blood volume and 
  vascular resistance due to sodium restriction.
In the sodium restriction group, there was only a mild 
decrease in CRAE after surgery. However, multiple regres-
sion analyses showed that an increase in CRAE was sig-
nificantly associated with diabetes mellitus, hyperlipidemia, 
and alcohol intake. Diabetes mellitus and hyperlipidemia are 
important risk factors for vascular disorders caused by arte-
rial sclerosis, and the onset frequencies of cerebrovascular 
disorders and ischemic cardiac diseases increase markedly 
when diabetes mellitus and hyperlipidemia are both   present.34 
Hypertension is similarly a well-defined risk factor for 
  arterial sclerosis. Studies in the US and Europe, such as the 
Framingham Study, have indicated that hypertension is a risk 
factor for coronary artery disease.35 In Japan, the Hisayama 
Study also shows that a blood pressure of 140/90 mmHg 
or greater significantly increases the frequency of cerebral 
infarction.36 Pathologic conditions, such as diabetes mellitus, 
hyperlipidemia, and hypertension, may also be closely related 
to metabolic syndrome, when viewed from the perspective 
of insulin resistance and fat accumulation around organs. 
Insulin resistance is a predictor of metabolic syndrome. 
Compared with subjects with normal blood pressure, patients 
with hypertension have insulin resistance,37,38 which may be 
due to increased visceral fat.39
Based on these findings, the improvement of insulin 
resistance, due to correction of diet and establishing of a 
controlled diet during hospitalization, may have increased 
CRAE in patients with diabetes mellitus and hyperlipidemia. 
Diabetes mellitus apparently influences retinal arteriolar 
diameter because previous epidemiologic surveys have 
reported significantly larger retinal arteriolar diameters in 
people with diabetes mellitus.12
We also note that long-term alcohol intake results in 
elevation of blood pressure.40 A reduction in alcohol intake 
lowers blood pressure by 80% within one to two weeks.41 
Because the hospitalized patients were unable to drink alco-
hol, an antihypertensive effect due to reduced alcohol intake 
may also have contributed to the increase in CRAE.
An increase in CRVE was associated with the Brink-
man Index. It has been noted that smoking causes transient 
blood pressure elevation, but a method for evaluating the 
chronic effect of smoking on blood pressure has not been 
established.42 Previous studies have shown that CRVE is 
significantly higher in smokers than in nonsmokers. However, 
it is unclear if the increase in CRVE in smokers results from 
a decreased blood pressure, results from compensation by 
the nervous system due to changes in body fluid volume, or 
is affected by smoking itself.12
The relationship between the decrease in CRVE and 
hyperlipidemia may be connected with an increase in HDL-C, 
correction of diet during hospitalization, and establishing a 
controlled diet.12
The relationship between a slight increase in CRVE and 
age may be connected with aging and presence of cataracts 
in the subjects. The resolution of the fundus photographs was 
low. The larger diameter of retinal venules compared with 
the diameter of retinal arterioles may have produced smaller 
errors that resulted in significant differences for CRVE.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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In addition, hospitalization could lead to a more 
regular regimen, regarding factors such as diet and drug 
  administration, compared with a patient’s ordinary life. These 
factors may influence the diameter of retinal vessels. There-
fore, in a future study we will also measure additional factors, 
including amount of sodium intake, insulin resistance, and 
various cholesterol levels.
Blood pressure control for one year is associated with an 
improvement in retinal arteriolar narrowing.13 Sodium restric-
tion for nine weeks has been shown to increase the diameter 
of the radial artery.14 Dollery et al reported that hypertension 
treatment did not significantly alter vessel diameter after half 
an hour, as measured manually from projections of retinal 
images.43 However, our study indicated that sodium restriction 
for one week caused a reduction of blood pressure and no sig-
nificant change in retinal arteriolar diameter. Because retinal 
arteriolar narrowing is believed to reflect structural dam-
age due to chronic hypertension,11 the effect of a one-week 
sodium restriction may not be measurable because vascular 
architecture changes may not have occurred within that time. 
Multiple regression analyses indicated that diabetes mellitus, 
hyperlipidemia, and alcohol intake are significantly associ-
ated with an increase in retinal arteriolar diameter. Sodium 
restriction and reducing blood pressure are important in terms 
of their relationship with cerebral vascular disorders. Sodium 
restriction for a longer period may show much clearer changes 
in retinal arteriolar diameter and may also cause similar 
changes in arterioles in the brain and kidney.
An original research study on sodium restriction should 
be performed in patients with hypertension without the 
loading of cataract surgery and sodium restriction (as in 
our study), but with the loading of sodium restriction only. 
However, in an actual clinical site, it is very difficult to find 
a group of patients with hypertension but without the loading 
of cataract surgery. In the future, original studies involving 
various internal medicine departments, as well as long-term 
research and population-based research, are required to inves-
tigate vascular changes under larger blood pressure changes. 
A study of hospitalized patients and a population-based study 
may also be required in the future.
In the analysis of diameter of the retinal vessels, the 
present study excluded patients with severe cataracts and 
invisible fundus. The results also seem to be affected by 
such a selection bias.
Using diabetes mellitus, hyperlipidemia, and alcohol-
ism as analysis factors, the patients with and without these 
diseases were evaluated. However, the actual extent of 
the diseases was not evaluated. In the future, factors such 
as blood glucose level, glycosylated hemoglobin level, 
  cholesterol level, and amount of alcohol consumption need 
to be calculated in detail and analyzed.
The sodium restriction group and the control group had 
significantly different average ages. The SBP responses to 
sodium intervention increased with age.44 Lower blood pres-
sure in the sodium restriction group may have been influenced 
by age. In the Blue Mountains Eye Study, the association of 
increased blood pressure with arteriolar narrowing dimin-
ished with increasing age.45 In both groups, the subjects were 
about 75 years of age or older, but the difference between 
each group’s average ages may have affected the results.
The computer-based method for measuring the diameter 
of retinal vessels permits quantification with greater accuracy 
and smaller errors, compared with previous methods. This 
method is not a subjective evaluation based on visual inspec-
tion, but is an objective method using digital processing.8 
Although no report exists concerning intraoperator correlation 
coefficients, the accuracy of the method is at the micron level; 
the interoperator correlation coefficients are 0.99 for arterial 
diameters and 0.94 for venous diameters, which demonstrates 
superior reproducibility and validity.20 The cross-sectional 
Beaver Dam Eye Study used this method and demonstrated 
that the retinal arteriolar diameter decreased by 4.0 µm with 
each 10 mmHg increase in mean arterial blood pressure.7 
Using the same method, the Funagata study showed that each 
10 mmHg increase in mean arterial blood pressure was associ-
ated with a 2.8 µm reduction in arteriolar diameter.10
This method will allow further examination of the relation-
ship between sodium restriction and hypertension. Based on 
minute changes in the diameter of retinal vessels, this method 
may also be useful in detecting systemic diseases such as 
hypertension and arteriosclerosis. It may also be useful for 
monitoring the effect of antihypertensive drug treatment.
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